03.10.2022 - CEO of Curis brings extensive biopharmaceutical financial experience to the Board LAWRENCEVILLE, N.J., Oct. 03, 2022 (GLOBE NEWSWIRE) - Imunon, Inc. (Nasdaq: IMNN), a clinical-stage drug development company, announces the appointment of James E. . Seite 1
Emerging applications of microneedle drug delivery systems are expected to fuel their demand over the next decade. According to a recent report published by Future Market Insights (FMI), the global microneedle drug delivery systems market will grow at a CAGR of 6.6% between 2020 and 2030. The market is witnessing su.
/PRNewswire/ As per Zion Market Research study, The global needle-free diabetes care market size was worth USD 9.1 billion in 2021 and is estimated to grow.
Emerging applications of microneedle drug delivery systems are expected to fuel their demand over the next decade. According to a recent report published by Future Market Insights (FMI), the global microneedle drug delivery systems market will grow at a CAGR of 6.6% between 2022 and 2030. The market is witnessing su.
/PRNewswire/ The global insulin pump market is expected to expand at a compound annual growth rate (CAGR) of 8.7% during the forecast period, reaching a.